| |
|
|
|
Evelo Biosciences Inc  
|
|
8.18 0.23 (0.03%) |
10-18 16:00 |
|
Open: |
7.87 |
Pre close: |
7.95 |
Target:
|
10.65
|
|
High: |
8.4 |
Low: |
7.87 |
Resistance:
|
9.12
10.65
|
|
Volume: |
386,771 |
Market Cap: |
446M |
Support:
|
7.03
5.74
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.88
 |
MACD |
MACD(12,26):
|
-0.19 |
|
MA(20): |
7.39 |
Signal(12,26,9): |
-0.41 |
|
MA(100): |
10.81  |
Stochastic Oscillator |
%K(14,3):
|
66.93 |
|
MA(250): |
10.74 |
%D(3): |
62.14 |
|
Average Volume(K) |
3-Month: |
32836
|
52-Week |
High:
|
19.93 |
|
10-Days: |
52575 |
Low: |
3.82 |
|
RSI |
RSI(14):
|
53.23 |
Change(%): |
70.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.230 |
Return on Equity (ttm) |
-155.4 |
Shares Out. (M) |
53.37 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-50.9 |
Shares Float (M) |
27.05 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.48 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
89.81 |
|
Forward EPS |
-2.780 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2540 |
|
Book Value (p.s.) |
1.650 |
EBITDA (p.s.) |
-1.762 |
P/E |
-3.67 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.96 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-79.83 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-52.59 |
P/CF |
-5.47 |
|
|
|
|
|
|
